Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin

Pharmacotherapy

Volumn 36, Issue 2, 2016, Pages e5-e7

  Wiggins, Barbara S ^a   Northup, Amanda ^b   Johnson, Dominic ^b   Senfield, Jeffrey ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

dabigatran; drug interaction; P glycoprotein; phenytoin

Indexed keywords

DABIGATRAN; FUROSEMIDE; LOSARTAN; METOPROLOL SUCCINATE; PHENYTOIN; POTASSIUM CHLORIDE; PRAVASTATIN; SOTALOL; SPIRONOLACTONE; ANTICONVULSIVE AGENT; ANTITHROMBIN;

ADULT; ARTICLE; ATRIAL FIBRILLATION; CASE REPORT; CEREBROVASCULAR ACCIDENT; DEFIBRILLATION; DRUG ANTAGONISM; DRUG BLOOD LEVEL; HEART VENTRICLE TACHYCARDIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTRACARDIAC THROMBOSIS; MALE; MIDDLE AGED; MINIMUM PLASMA CONCENTRATION; MORNING DOSAGE; SEIZURE; TANDEM MASS SPECTROMETRY; BLOOD; COMPLICATION; DRUG INTERACTION; DRUG MONITORING; PULMONARY EMBOLISM; SECONDARY PREVENTION; SEIZURES; TREATMENT OUTCOME; VENOUS THROMBOSIS;

ANTICONVULSANTS; ANTITHROMBINS; DABIGATRAN; DRUG INTERACTIONS; DRUG MONITORING; HUMANS; MALE; MIDDLE AGED; PHENYTOIN; PULMONARY EMBOLISM; SECONDARY PREVENTION; SEIZURES; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 84958930294     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/phar.1698     Document Type: Article

References (9)

1. Prescribing information. Pradaxa (dabigatran etexilate). Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc., 2010.
2. Reilly PA, Lehr T, Haertter S, et al., The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients. The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). J Am Coll Cardiol 2014; 63 (4): 321-328.
3. Prescribing information. Xarelto (rivaroxaban) Titusville, NJ: Janssen Pharmaceuticals Inc., 2011.
4. Product monograph. Xarelto (rivaroxaban) Toronto, ON, Canada: Bayer Inc., 2008.
5. Prescribing information. Eliquis (apixaban). New York: Pfizer Inc., 2012.
6. Product monograph. Eliquis (apixaban). Kirkland, QC: Pfizer Canada Inc., 2012.
7. Center for Drug Evaluation and Research. Application Number: 206316Orig1Orig2s000. Clinical Pharmacology and Biopharmaceutics Review. Food and Drug Administration. Available at http://www.accessdata.fda.gov/drugsatfda-docs/nda/2015/206316Orig1Orig2s000ClinPharmR.pdf.
8. Prescribing information. Savaysa (edoxaban). Parsippany, NJ: Daiichi Sankyo, Inc., 2015.
9. Prescribing information. Pradaxa (Dabigatran etexilate). Germany: Boehringer Ingelheim Internation GmbH. http://www.ema.europa.eu/docs/en-GB/document-library/EPAR---Product-Information/human/000829/WC500041059.pdf.